| Butterfield Park Pediatrics | |
|
1195 N Oakland Ave Suite 2 Bolivar MO 65613-8095 | |
| (417) 777-2121 | |
| (417) 777-2854 |
| Full Name | Butterfield Park Pediatrics |
|---|---|
| Speciality | Clinic/Center |
| Location | 1195 N Oakland Ave, Bolivar, Missouri |
| Authorized Official Name and Position | Donald J Babb (CEO) |
| Authorized Official Contact | 4173266000 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Butterfield Park Pediatrics 1195 N Oakland Ave Bolivar MO 65613-8095 Ph: (417) 777-2121 | Butterfield Park Pediatrics 1195 N Oakland Ave Suite 2 Bolivar MO 65613-8095 Ph: (417) 777-2121 |
| NPI Number | 1942414610 |
|---|---|
| Provider Enumeration Date | 05/10/2007 |
| Last Update Date | 11/06/2018 |
| Medicare PECOS PAC ID | 4183528169 |
|---|---|
| Medicare Enrollment ID | O20080125000591 |
News Archive
The U.S. Food and Drug Administration is requesting a total budget of $6.5 billion as part of the President's fiscal year (FY) 2022 budget - a nearly 8% ($477 million) increase over the agency's FY 2021 funding level for investments in critical public health infrastructure, core food safety and medical product safety programs and other vital public health programs.
Nuffield Health Leeds Hospital announced today that it will be the first hospital in the UK to offer the incisionless TOGA® Procedure for treatment of obesity commencing in January 2011. The TOGA Procedure has been used to treat over 450 patients worldwide - its incision-free approach is very minimally invasive and offers the benefits of minimal pain and downtime, and an excellent safety profile.
Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942414610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (* (Not Available)) | Secondary |
| 261QR1300X | Clinic/center - Rural Health | (* (Not Available)) | Primary |
News Archive
The U.S. Food and Drug Administration is requesting a total budget of $6.5 billion as part of the President's fiscal year (FY) 2022 budget - a nearly 8% ($477 million) increase over the agency's FY 2021 funding level for investments in critical public health infrastructure, core food safety and medical product safety programs and other vital public health programs.
Nuffield Health Leeds Hospital announced today that it will be the first hospital in the UK to offer the incisionless TOGA® Procedure for treatment of obesity commencing in January 2011. The TOGA Procedure has been used to treat over 450 patients worldwide - its incision-free approach is very minimally invasive and offers the benefits of minimal pain and downtime, and an excellent safety profile.
Introgen Therapeutics has announced that it was successful in winning the decision regarding its opposition of European Patent 0 390 323 before the European Patent Office (EPO) in which all claims directed to therapeutic applications of the p53 gene, the active component of Introgen's Advexin molecular therapy, were finally revoked by the EPO's Technical Board of Appeals.
JDRF, in collaboration with The Leona M. and Harry B. Helmsley Charitable Trust (HCT), announced today that it has finalized a grant in the area of islet cell encapsulation to Dr. Camillo Ricordi, M.D. and a team of investigators at the Diabetes Research Institute (DRI), based at the University of Miami (FL).
› Verified 8 days ago
Bolivar Family Care Center, Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1240 N Butterfield Rd, Bolivar, MO 65613 Phone: 417-326-6021 Fax: 417-326-6347 | |
Bolivar Family Care Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1240 N Butterfield Rd, Bolivar, MO 65613 Phone: 417-326-6021 Fax: 417-326-6347 | |
Ozarks Community Health Center - Miles For Smiles Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 203 E. Broadway St., Bolivar, MO 65613 Phone: 417-328-6334 Fax: 417-326-8111 | |
Bolivar Family Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1240 N Butterfield Rd, Bolivar, MO 65613 Phone: 417-326-6021 | |
Doctors Testing Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 413 S Springfield Ave, Bolivar, MO 65613 Phone: 417-326-2654 Fax: 417-326-2654 | |
Bolivar Medical Center, Inc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1120 S Springfield Ave, Bolivar, MO 65613 Phone: 417-326-4000 Fax: 417-326-6400 | |
Carl L. Blomenkamp,d.c.,p.c. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 2853 W Broadway St, Bolivar, MO 65613 Phone: 417-326-3888 |